Elijovich F, Krakoff L R
Clin Exp Hypertens A. 1982;4(9-10):1795-814. doi: 10.3109/10641968209061642.
The effect of captopril was explored in salt-depleted methylprednisolone (MP)-hypertensive rats. MP treatment raised BP by 41+/-2 mmHg over 2 weeks. Controls (C) had no change in BP. Sodium balance and weight data indicated a greater salt depletion in MP than in C. On day 15, captopril reduced BP in both MP (20+/-4 mmHg) and C (31+/-4 mmHg). The effect was significantly smaller in MP than in C (p less than 0.05). Plasma renin activity (PRA) was similarly elevated in both groups, consistent with salt depletion. Serum (SCE) and lung-converting enzyme (LCE) activity were similar in MP and C. The diminished antihypertensive effect of captopril in MP is therefore not attributable to differences in PRA, SCE, or LCE. Our data suggest that depressor actions of captopril unrelated to the renin-angiotensin system are impaired in MP. Glucocorticoid-induced changes in vasodilator systems may explain these findings.
在低盐饮食的甲基强的松龙(MP)诱导的高血压大鼠中探究了卡托普利的作用。MP治疗在2周内使血压升高了41±2 mmHg。对照组(C)血压无变化。钠平衡和体重数据表明,MP组比C组的盐缺失更严重。在第15天,卡托普利使MP组(20±4 mmHg)和C组(31±4 mmHg)的血压均降低。MP组的降压效果明显小于C组(p<0.05)。两组的血浆肾素活性(PRA)均同样升高,这与盐缺失一致。MP组和C组的血清(SCE)和肺转化酶(LCE)活性相似。因此,卡托普利在MP组中降压作用减弱并非归因于PRA、SCE或LCE的差异。我们的数据表明,MP会损害卡托普利与肾素-血管紧张素系统无关的降压作用。糖皮质激素诱导的血管舒张系统变化可能解释了这些发现。